Dynorphin Knockout Reduces Fat Mass and Increases Weight Loss during Fasting in Mice

Molecular Endocrinology

Volumn 21, Issue 7, 2007, Pages 1722-1735

  Sainsbury, Amanda ^a   Lin, Shu ^a   McNamara, Keely ^a   Slack, Katy ^a   Enriquez, Ronaldo ^a   Lee, Nicola J ^a   Boey, Dana ^a   Smythe, George A ^b   Schwarzer, Christoph ^a,c   Baldock, Paul ^a   Karl, Tim ^a,d   Lin, En Ju D ^a   Couzens, Michelle ^a   Herzog, Herbert ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d Neuroscience Institute of Schizophrenia and Allied Disorders   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; APPETITE STIMULANT; DYNORPHIN; FAT; FATTY ACID; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; ENERGY BALANCE; ENERGY EXPENDITURE; FAT BODY; FATTY ACID OXIDATION; FEMALE; FOOD INTAKE; HOMEOSTASIS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; KNOCKOUT MOUSE; LIPID ABSORPTION; LIPID OXIDATION; LUNG GAS EXCHANGE; MALE; MOUSE; NEUROENDOCRINOLOGY; NONHUMAN; NUTRIENT MANAGEMENT; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTERACTION; THALAMUS MIDLINE NUCLEUS; THERMOREGULATION; WEIGHT REDUCTION; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DYNORPHINS; EATING; ENERGY METABOLISM; EXERTION; FASTING; FEMALE; GLUCOSE; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; NEUROSECRETORY SYSTEMS; RNA, MESSENGER; WEIGHT LOSS;

MUS;

EID: 34347255035     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0367     Document Type: Article

References (56)

1. Glass MJ, Billington CJ, Levine AS 2000 Opioids, food reward, and macronutrient selection. In: Berthoud HR, Seeley RJ, eds. Neural and metabolic control of macronutrient intake. New York: CRC Press; 407-423
2. El-Tayeb KM, Brubaker PL, Lickley HL, Cook E, Vranic M 1986 Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation. Am J Physiol 250:E236-E242
3. Gunion MW, Rosenthal MJ, Morley JE, Miller S, Zib B, Butler B, Moore RD 1991 μ-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides. Am J Physiol 261:R70-R81
4. Khawaja XZ, Green IC, Thorpe JR, Titheradge MA 1990 The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain. Biochem J 267:233-240
5. Civelli O, Douglass J, Goldstein A, Herbert E 1985 Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 82:4291-4295
6. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, Elmquist JK 2000 Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423:261-281
7. Berman Y, Devi L, Spangler R, Kreek MJ, Carr KD 1997 Chronic food restriction and streptozotocin-induced diabetes differentially alter prodynorphin mRNA levels in rat brain regions. Brain Res Mol Brain Res 46:25-30
8. Herve C, Fellmann D 1997 Changes in rat melanin-concentrating hormone and dynorphin messenger ribonucleic acids induced by food deprivation. Neuropeptides 31:237-242
9. Khawaja XZ, Chattopadhyay AK, Green IC 1991 Increased beta-endorphin and dynorphin concentrations in discrete hypothalamic regions of genetically obese (ob/ob) mice. Brain Res 555:164-168
10. Khawaja XZ, Green IC, Thorpe JR, Bailey CJ 1990 Increased sensitivity to insulin-releasing and glucoregulatory effects of dynorphin A1-13 and U 50488h in ob/ob versus lean mice. Diabetes 39:1289-1297
11. Lambert PD, Wilding JP, al-Dokhayel AA, Bohuon C, Comoy E, Gilbey SG, Bloom SR 1993 A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. Endocrinology 133:29-32
12. Cole JL, Leventhal L, Pasternak GW, Bowen WD, Bodnar RJ 1995 Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res 678:168-176
13. Jarosz PA, Metzger BL 2002 The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating. Biol Res Nurs 3:198-209
14. Herzog H 2003 Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol 480:21-29
15. Erickson JC, Hollopeter G, Palmiter RD 1996 Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707
16. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
17. Sainsbury A, Schwarzer C, Couzens M, Fitissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hokfelt T, Herzog H 2002 Important role of hypothalamic Y2 receptors in bodyweight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 99:8938-8943
18. Kask A, Rago L, Korrovits P, Wikberg JE, Schioth HB 1998 Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y. Biochem Biophys Res Commun 248:245-249
19. Kotz CM, Grace MK, Briggs J, Levine AS, Billington CJ 1995 Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat: neural site of action. J Clin Invest 96:163-170
20. Kotz CM, Grace MK, Billington CJ, Levine AS 1993 The effect of norbinaltorphimine, β-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res 631:325-328
21. Pomonis JD, Levine AS, Billington CJ 1997 Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression. J Neurosci 17:5175-5182
22. Erickson JC, Ahima RS, Hollopeter G, Flier JS, Palmiter RD 1997 Endocrine function of neuropeptide Y knockout mice. Regul Pept 70:199-202
23. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382:250-252
24. Lewitt MS, Brismar K, Wang J, Wivall-Helleryd IL, Sindelar P, Gonzalez FJ, Bergman T, Bobek GA 2001 Responses of insulin-like growth factor (IGF)-I and IGF-binding proteins to nutritional status in peroxisome proliferator-activated receptor-α knockout mice. Growth Horm IGF Res 11:303-313
25. McKnight BJ, Goddard C 1989 The effect of food restriction on circulating insulin-like growth factor-I in mice divergently selected for high or low protein or fat to body mass ratios. Comp Biochem Physiol 92:565-569
26. Paczoska-Eliasiewicz HE, Gertler A, Proszkowiec M, Proudman J, Hrabia A, Sechman A, Mika M, Jacek T, Cassy S, Raver N, Rzasa J 2003 Attenuation by leptin of the effects of fasting on ovarian function in hens (Gallus domesticus). Reproduction 126:739-751
27. Sarkar S, Legradi G, Lechan RM 2002 Intracerebroventricular administration of α-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRH-producing neurons of the hypothalamic paraventricular nucleus. Brain Res 945:50-59
28. Gruenewald DA, Matsumoto AM 1993 Reduced gonadotropin-releasing hormone gene expression with fasting in the male rat brain. Endocrinology 132:480-482
29. Park S, Sohn S, Kineman RD 2004 Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J Endocrinol 180:369-378
30. Fekete C, Legradi G, Mihaly E, Tatro JB, Rand WM, Lechan RM 2000 α-Melanocyte stimulating hormone prevents fasting-induced suppression of corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus. Neurosci Lett 289:152-156
31. Elia M, Livesey G 1992 Energy expenditure and fuel selection in biological systems: the theory and practice of calculations based on indirect calorimetry and tracer methods. World Rev Nutr Diet 70:68-131
32. Eisenhofer G, Kopin IJ, Goldstein DS 2004 Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331-349
33. Lin S, Boey D, Lee N, Schwarzer C, Sainsbury A, Herzog H 2006 Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain. Neuropeptides 40:115-123
34. Szeto HH 2003 Dynorphin and the hypothalamo-pituitary-adrenal axis during fetal development. Life Sci 73:749-758
35. Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G 2006 Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology 31:1928-1937
36. Barnes MJ, Jen KL, Dunbar JC 2004 The effect of CNS opioid on autonomic nervous and cardiovascular responses in diet-induced obese rats. Peptides 25:71-79
37. Dumont M, Lemaire S 2000 Interactions of dynorphin A-(1-13) and nociceptin with cardiac D2 binding sites: inhibition of ischemia-evoked release of noradrenaline from synaptosomal-mitochondrial fractions. J Mol Cell Cardiol 32:1567-1574
38. Millan MJ, Herz A 1985 The endocrinology of the opioids. Int Rev Neurobiol 26:1-83
39. d'Amore A, Mazzucchelli A, Renzi P, Loizzo A 1996 Effect of naloxone on the long-term body weight gain induced by repeated postnatal stress in male mice. Behav Pharmacol 7:430-436
40. Pol O, Valle L, Sanchez-Blazquez P, Garzon J, Puig MM 1999 Antibodies and antisense oligodeoxynucleotides to μ-opioid receptors, selectively block the effects of μ-opioid agonists on intestinal transit and permeability in mice. Br J Pharmacol 127:397-404
41. Satchithanandam S, Vargofcak-Apker M, Calvert RJ, Leeds AR, Cassidy MM 1990 Alteration of gastrointestinal mucin by fiber feeding in rats. J Nutr 120:1179-1184
42. Curd CD, Manno JE, Stewart JJ 1985 Effects of methotrexate on intestinal transit in rats. Fundam Appl Toxicol 5:991-996
43. Koteja P, Carter PA, Swallow JG, Garland Jr T 2003 Food wasting by house mice: variation among individuals, families, and genetic lines. Physiol Behav 80:375-383
44. Kerley G, Erasmus T 1991 What do mice select for in seeds? Oecologia 86:261-267
45. Woods SC, Lutz TA, Geary N, Langhans W 2006 Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc B Biol Sci 361:1219-1235
46. Parker RM, Herzog H 1999 Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11:1431-1448
47. Rohner-Jeanrenaud F 1995 A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. Int J Obes Relat Metab Disord 19:517-534
48. Febo M, Jimenez-Rivera CA, Segarra AC 2002 Estrogen and opioids interact to modulate the locomotor response to cocaine in the female rat. Brain Res 943:151-161
49. Foradori CD, Coolen LM, Fitzgerald ME, Skinner DC, Goodman RL, Lehman MN 2002 Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus. Endocrinology 143:4366-4374
50. Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C 2007 Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via κ opioid receptors. Brain 130:1017-1028
51. Howell OW, Scharfman HE, Beck-Sickinger AG, Herzog H, Gray WP 2003 Neuropeptide Y is neuroproliferative in primary hippocampal cultures. J Neurochem 86:646-659
52. Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, Sainsbury A 2002 Chronic central melanocortin-4 receptor antagonism and central neuropeptide-y infusion in rats produce increased adiposity by divergent pathways. Diabetes 51:152-158
53. Folch JMS, Less M, Stanley GHS 1956 A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226:497-509
54. Sainsbury A, Schwarzer C, Couzens M, Herzog H 2002 Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51:3420-3427
55. Smythe GA, Edwards G, Graham P, Lazarus L 1992 Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clin Chem 38:486-492
56. Gotoh M, Iguchi A, Kakumu S, Hirooka Y, Smythe GA 2001 Central suppressive effect of octreotide on the hyperglycemic response to 2-deoxy-D-glucose injection or cold-swim stress in awake rats: possible mediation role of hypothalamic noradrenergic drive. Brain Res 895:146-152